{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-032729","form_type":"8-K","ticker":"CLDI","cik":"0001855485","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2023-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.184138+00:00","generated_at":"2026-06-19T18:23:38.117825+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"FLAG amends merger with Calidi; Continuation Shares to be issued at closing without price targets","bullets":["Up to 2,000,000 Continuation Shares to be issued pro rata to non-redeeming FLAG public stockholders at closing.","For every 100,000 shares not redeemed, FLAG issues 48,450 Continuation Shares, capped at 2M total.","Amendment removes prior price-target condition; Continuation Shares now issued automatically at deal close.","Amendment signed Feb 9, 2023; business combination with Calidi Biotherapeutics remains pending."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-032729","json":"https://secwatch.observer/filing/0001193125-23-032729.json","markdown":"https://secwatch.observer/filing/0001193125-23-032729.md","text":"https://secwatch.observer/filing/0001193125-23-032729.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000119312523032729/0001193125-23-032729-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000119312523032729/d442631d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T18:23:38.117825+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"63173d4a5736d87a8da66807827d6e29462a8ea8","claim":"Calidi Biotherapeutics, Inc. amended Amendment No. 1 to the Merger Agreement with First Light Acquisition Group, Inc. (FLAG), Calidi Biotherapeutics, Inc., First Light Acquisition Group, LLC (as Purchaser Representative), and Allan Camaisa (as Seller Representative) (effective 2023-02-09).","evidence_excerpt":"On February 9, 2023, FLAG, Calidi, the Purchaser Representative and the Seller Representative entered into Amendment No. 1 to the Merger Agreement (the “ Amendment ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855485/000119312523032729/0001193125-23-032729-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"First Light Acquisition Group, Inc. (FLAG), Calidi Biotherapeutics, Inc., First Light Acquisition Group, LLC (as Purchaser Representative), and Allan Camaisa (as Seller Representative)"},{"label":"Effective","value":"2023-02-09"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}